Elsevier

Sleep Medicine Reviews

Volume 5, Issue 1, February 2001, Pages 7-23
Sleep Medicine Reviews

Regular Article
Optimal continuous positive airway pressure for the treatment of obstructive sleep apnea/hypopnea,☆☆

https://doi.org/10.1053/smrv.2000.0131Get rights and content

Abstract

The obstructive sleep apnea/hypopnea syndrome (OSA/H) is characterised by repetitive obstruction of the upper airway during sleep. The consequences of OSA/H include excessive daytime sleepiness, reduced perceived health quality and an increased risk of driving accidents. There is evidence that treatment with nasal continuous positive airway pressure (CPAP) is effective in eliminating these consequences. In addition, OSA/H may also be associated with hypertension and an increased risk of vascular disease, and although there is no clear evidence in this regard, CPAP may be effective alleviating these consequences as well. Nasal CPAP is considered the treatment of choice for clinically significant OSA/H. The optimal CPAP prescription is that which is most effective in eliminating the adverse consequences of OSA/H. Patients should be initially treated with standard CPAP. For those in whom standard CPAP is unsuccessful or intolerable bi-level or self-adjusting modes may be attempted. The nasal CPAP pressure level can be titrated to eliminate apnea, hypopnea, snoring, respiratory arousal and inspiratory flow limitation as a means of predicting successful long-term therapy. The reliability of these physiologic parameters in predicting the optimal long-term CPAP pressure is eroded by the tendency of CPAP pressure-level requirement to decrease with chronic CPAP use, and by other factors that may increase the CPAP pressure requirement. The split-night polysomnogram and unattended auto-CPAP titration have been proposed as efficient means of determining the optimal CPAP pressure, but for patients with subtle OSA/H, underlying cardiopulmonary disease or other forms of sleep-disordered breathing a full-night polysomnogram may be required. The CPAP prescription must include a comfortable well-fitting interface. When CPAP is prescribed it is essential that the patient undergo clinical re-evaluation to ensure that treatment goals are being met.

References (69)

  • W Beninati et al.

    The effect of snoring and obstructive sleep apnea on the sleep quality of bed partners: the spousal arousal syndrome

    Mayo Clinic Proceedings

    (1999)
  • A Oksenberg et al.

    The sleep supine position has a major effect on optimal nasal continuous positive airway pressure: relationship with rapid eye movements and non-rapid eye movements sleep, body mass index, respiratory disturbance, and age

    Chest

    (1999)
  • R Jokic et al.

    Continuous positive airway pressure requirements during the first month of treatment in patients with severe obstructive sleep apnea

    Chest

    (1998)
  • C Guilleminault et al.

    A cause of excessive daytime sleepiness: the upper airway resistance syndrome

    Chest

    (1993)
  • I Ayappa et al.

    Relative occurrence of flow limitation and snoring during continuous positive airway pressure titration

    Chest

    (1998)
  • Y Yamashiro et al.

    CPAP titration for sleep apnea using a split-night protocol

    Chest

    (1995)
  • MH Sanders et al.

    Obstructive sleep apnea treated by independently adjusted inspiratory and expiratory positive airway pressures via nasal mask: physiologic and clinical implications

    Chest

    (1990)
  • HM Engleman et al.

    Effect of continuous positive airway pressure treatment on daytime function in sleep apnoea/hypopnoea syndrome

    Lancet

    (1994)
  • MH Sanders et al.

    CPAP therapy via oroÍnasal mask for obstructive sleep apnea

    Chest

    (1994)
  • GL Prosise et al.

    Oral-nasal continuous positive airway pressure as a treatment for obstructive sleep apnea

    Chest

    (1994)
  • CA Massie et al.

    Effects of humidification on nasal symptoms and compliance in sleep apnea patients using continuous positive airway pressure

    Chest

    (1999)
  • American Academy of Sleep Medicine Task Force

    Sleep-related breathing disorders in adults: recommendations for syndrome definition and measurement techniques in clinical research

    Sleep

    (1999)
  • T Young et al.

    The occurrence of sleep disordered breathing among middle-aged adults

    N Engl J Med

    (1993)
  • E Ballester et al.

    Evidence of the effectiveness of continuous positive airway pressure in the treatment of sleep apnea/hypopnea syndrome

    Am J Respir Crit Care Med

    (1999)
  • S Redline et al.

    Improvement of mild sleep-disordered breathing with CPAP compared with conservative therapy

    Am J Respir Crit Care Med

    (1998)
  • HM Engleman et al.

    Randomised placebo controlled trial of daytime function after continuous positive airway pressure (CPAP) therapy for the sleep apnoea/hypopnoea syndrome

    Thorax

    (1998)
  • HM Engleman et al.

    Randomized placebo-controlled crossover trial of continuous positive airway pressure for mild sleep apnea/hypopnea syndrome

    Am J Respir Crit Care Med

    (1999)
  • J Teran-Santos et al.

    The association between sleep apnea and the risk of traffic accidents

    N Engl J Med

    (1999)
  • CFP George et al.

    Sleep apnea and automobile crashes

    Sleep

    (1999)
  • T Young et al.

    Population-based study of sleep-disordered breathing as a risk factor for hypertension

    Arch Intern Med

    (1997)
  • D Brooks et al.

    Obstructive sleep apnea as a cause of systemic hypertension: evidence from a canine model

    J Clin Invest

    (1997)
  • SF Quan et al.

    The Sleep Heart Health Study: design, rationale, and methods

    Sleep

    (1997)
  • PJ Strollo et al.

    Obstructive sleep apnea

    N Engl J Med

    (1996)
  • NC Abbey et al.

    Benefit of nasal CPAP in obstructive sleep apnea is due to positive pharyngeal pressure

    Sleep

    (1989)
  • Cited by (0)

    Correspondence should be addressed to: Lt Col William Beninati, Pulmonary/Critical Care Medicine Division, 2200 Berquist Drive, Lackland AFB, TX782365300, USA.

    ☆☆

    The views expressed in this article are those of the authors and do not reflect the official policy of the Department of Defense or the US Government.

    View full text